In this study, the frequencies of TP53 and XPD genotype in the lung cancer patients according to tumor stage IIIA and IIIB (Lung cancer stage group accordance with TNM classification) (Liu and Zhi, 2015) were also analyzed but no significant association of these polymorphisms with tumor stages was observed. The gene discussed is TP53; the disease is lung carcinoma.